林霞

LX
博士後研究員

公共衞生實驗室科學

  • PhD
phone 2831 5488
email linxia@hku.hk
個人簡介

Dr Lin obtained her PhD from Guangzhou Medical University, China, and her research was performed at the State Key Laboratory for Respiratory Diseases. Her research interest is to understand how infection with novel antigenic subtype of influenza viruses shapes the existing antibody landscapes in individuals of different ages. She is also interested in establishing animal models to evaluate the effect of pre-existing immunity/imprinting on induction of antibody response following subsequent infection.

發表的部分文章
  1. Kang M, Lin F, Jiang Z, Tan X, Lin X, Liang Z, Xiao C, Xia Y, Guan W, Yang Z, Yu G, Zanin M, Tang S, Wong SS. The impact of pre-existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults. Influenza Other Respir Viruses. 2023 Jul 12;17(7):e13172. doi: 10.1111/irv.13172. (IF: 5.606, JR: 48/123 in Infectious Disease, Citations: 0)
  2. Chen L, Yu S, Hong S, Lin X, Zhu X, Cao X, Li Y, Xiao H. Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathway. Drug Dev Res. 2022 Dec 21. doi: 10.1002/ddr.22020. (IF: 5.004, JR: 19/63 in chemistry and medicinal, Citations: 0)
  3. Lin X, Lin F, Liang T, Ducatez MF, Zanin M, Wong SS. Antibody Responsiveness to Influenza: What Drives It? Viruses. 2021 Jul 19;13(7):1400. doi: 10.3390/v13071400. (IF: 5.818, JR: 14/38 in virology, Citations: 2)
  4. Xiao C, Leung NHL, Cheng Y, Lei H, Ling S, Lin X, Tao R, Huang X, Guan W, Yang Z, Cowling BJ, Zanin M, Wong SS. Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020. Pathogens. 2021 10(11):1505. doi: 10.3390/pathogens10111505. (IF: 4.531, JR: 79/157 in Microbiology, Citations: 1)
  5. Xiao C, Ling S, Qiu M, Deng Z, Chen L, Zhu A, Chen Y, Liu Y, Lin X, Lin F, Wu Q, Shen L, Ye F, Liu X, Li Y, Zhao J, Yang Z, Cowling BJ, Webby R, Zanin M, Wong SS. Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2. Influenza Other Respir Viruses. 2021 15(1):7-12. doi: 10.1111/irv.12798. (IF: 5.606, JR: 48/123 in Infectious Disease, Citations: 3)
  6. Zanin M, Xiao C, Liang T, Ling S, Zhao F, Huang Z, Lin F, Lin X, Jiang Z, Wong SS. The public health response to the COVID-19 outbreak in mainland China: a narrative review. J Thorac Dis. 2020 Aug;12(8):4434-4449. doi: 10.21037/jtd-20-2363. (IF: 3.005, JR: 55/98 in respiratory system, Citations: 12)
返回